EyeGene Inc Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - EyeGene Inc

Watchlist Manager

Watchlist

Price: 2 015 KRW -0.74% Market Closed

Market Cap: ₩87.1B

E	EyeGene Inc KOSDAQ:185490	KR
	Tasfoods Ltd ASX:TFL	AU
	Exopharm Ltd ASX:EX1	AU
S	Scan Inter PCL SET:SCN	TH
O	Orogen Royalties Inc F:5EV	CA
A	Altaley Mining Corp XTSX:ATLY	CA
C	Carpathia Capital SA WSE:CRC	PL
C	Clearday Inc OTC:CLRD	US
I	IMC SA F:IM4	UA
	Asahi Co Ltd OTC:AAHIF	JP

Profitability Summary

EyeGene Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

30%

Sustainable 3Y Average Gross Margin

43%

Declining Gross Margin

53% > 30%

Negative Operating Margin

-271%

Negative 3Y Average Operating Margin

-490%

Operating Margin is Increasing

-638% > -271%

Negative Net Margin

-403%

Negative 3Y Average Net Margin

-437%

Net Margin is Increasing

-557% > -403%

Negative Free Cash Flow Margin

-179%

Negative 3Y Average Free Cash Flow Margin

-470%

Free Cash Flow Margin is Increasing

-487% > -179%

Negative ROE

-31%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-72%

ROIC is Increasing

-179% > -43%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.